Skip to main content
Clinical Trials/NCT05113550
NCT05113550CompletedNot Applicable

Surgical Treatment of Hepatic Hydatidosis in Elderly Patients

Universidad de Extremadura2 sites in 1 country279 target enrollmentStarted: January 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
279
Locations
2
Primary Endpoint
Morbidity

Study Overview

Brief Summary

Cystic echinococcosis is a clinically complex chronic parasitic disease and a major socioeconomic problem in endemic areas. The safety of liver resection in elderly patients is often debated among medical professionals. The investigators analyzed the postoperative morbidity and mortality rates of elderly patients who underwent surgery at our unit.

Detailed Description

Retrospective observational study from prospective database focused on liver hydatidosis carried out at our Hepato-Pancreato-Biliary Surgery Unit. The study period spanned from January 2006 to October 2020. The study was approved by the Research Ethics Committee of our hospital. An informed consent from the patient was not required since the study was retrospective and observational, and entailed no risk. Seventy years of age was the cutoff age to consider patients as elderly.

Inclusion criteria of patients: liver hydatid cyst (LHC) diagnosed by preoperative computed tomography (CT) or magnetic resonance imaging (MRI) and pathological diagnosis after surgery, and LHC treated by total or partial pericystectomy.

Exclusion criteria of patients: emergency surgery and simple drainage of cyst.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • liver hydatid cyst (LHC)
  • pathological diagnosis after surgery
  • LHC treated by total or partial pericystectomy

Exclusion Criteria

  • emergency surgery and simple drainage of cyst

Outcomes

Primary Outcomes

Morbidity

Time Frame: 90 days

Patients with postoperative morbidity according to the Clavien-Dindo score 19, "severe complication" (Clavien-Dindo ≥ IIIa) and postoperative mortality

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Universidad de Extremadura
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Gerardo Blanco-Fernández

Profesor

Universidad de Extremadura

Study Sites (2)

Loading locations...

Similar Trials

Surgical Treatment of Hepatic Hydatidosis... | Clinical Trial